RBC: Strong Quarter, Wellbutrin Deal Ahead for Biovail - Seeking Alpha

"Biovail Corp. (BVF), whose shares have risen more than 60% in the past six months after the company in late October 2006 hiked its dividend, said it would make a one-time payment to shareholders, dropped its U.S. sales forecast and made management changes, will likely have investors listening for news related to its Wellbutrin antidepressant when the company’s quarterly financial results come out."